BFRI · Biofrontera
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
660 Main Street, Woburn, MA, 01801, United States
Drug Manufacturers - Specialty & Generic
Healthcare
Market Cap
12.2M
52 Wk Range
$0.56 - $1.66
Previous Close
$0.85
Open
$0.88
Volume
203,730
Day Range
$0.82 - $0.92
Enterprise Value
20.21M
Cash
4.667M
Avg Qtr Burn
-1.658M
Insider Ownership
11.99%
Institutional Own.
20.72%
Qtr Updated
Jun 30th 2026
